{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:58:12Z","timestamp":1785002292985,"version":"3.55.0"},"reference-count":111,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"},{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/14760584.2022.2021881","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T12:17:17Z","timestamp":1643026637000},"page":"325-335","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":21,"title":["Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-4735","authenticated-orcid":false,"given":"Woo-Yun","family":"Sohn","sequence":"first","affiliation":[{"name":"GSK, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-6412","authenticated-orcid":false,"given":"Halima","family":"Tahrat","sequence":"additional","affiliation":[{"name":"GSK, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-4672","authenticated-orcid":false,"given":"Patricia","family":"Novy","sequence":"additional","affiliation":[{"name":"GSK, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0683-6055","authenticated-orcid":false,"given":"Rafik","family":"Bekkat-Berkani","sequence":"additional","affiliation":[{"name":"GSK, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_1"},{"key":"cit0002","unstructured":"World Health Organization. Fact sheet. Meningococcal meningitis. Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/meningococcal-meningitis. Accessed: May 2020."},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)67932-4"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70180-1"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.2174\/1871526515999150320155614"},{"key":"cit0007","unstructured":"European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. Available from: https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx?Dataset=27&HealthTopic=36. Accessed: Apr 2021."},{"key":"cit0008","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2017. Available from: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2017.pdf. Accessed: Nov 2020."},{"key":"cit0009","unstructured":"Centers for Disease Control and Prevention. Enhanced meningococcal disease surveillance report, 2018. Available from: https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2018.pdf. Accessed: May 2020."},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101521"},{"key":"cit0011","unstructured":"European Medicines Agency. Bexsero. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/bexsero. Accessed: Jun 2021."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.058"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.04.031"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.20449"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901229"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(18)30103-2"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1244"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.050"},{"issue":"7","key":"cit0019","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/OLQ.0000000000001332","volume":"48","author":"Abara WE","year":"2021","journal-title":"Sex Transm Dis"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx180.002"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.3201\/eid2503.181574"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0155-7"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1547637"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.07.034"},{"key":"cit0026","unstructured":"Govern d\u2019Andorra. Ministeri de Salut. Nota informativa. Recomanacions sobre l\u2019administraci\u00f3 de la vacunaci\u00f3enfront del meningococ B (Bexsero). February 2016. Available from: https:\/\/www.salut.ad\/images\/stories\/Salut\/pdfs\/temes_salut\/Recomanacions_Vacuna_Bexero.pdf. Accessed: May 2020."},{"key":"cit0027","unstructured":"Ministry of Health Argentina. Argentina\u2019s meningococcal vaccination strategy guidelines. Available from: https:\/\/bancos.salud.gob.ar\/recurso\/huespedes-especiales-estrategia-de-vacunacion-contra-meningococo-de-argentina Accessed 2021 Dec 8."},{"key":"cit0028","unstructured":"Australian Government Department of Health. National Immunisation Program. Meningococcal vaccination schedule from 2020 Jul 1. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2020\/06\/national-immunisation-program-meningococcal-vaccination-schedule-from-1-july-2020-clinical-advice-for-vaccination-providers.pdf. Accessed: Oct 2020."},{"key":"cit0029","unstructured":"Government of South Australia. Meningococcal B immunisation program. Available from: https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/public+content\/sa+health+internet\/conditions\/immunisation\/immunisation+programs\/meningococcal+b+immunisation+program Accessed: 2021 Dec 8."},{"key":"cit0030","unstructured":"Federal Ministry of Health Austria. Impfplan Osterreich. Available from: https:\/\/www.sozialministerium.at\/Themen\/Gesundheit\/Impfen\/Impfplan-%C3%96sterreich.html Accessed 2021 Dec 8."},{"key":"cit0031","unstructured":"Superior Council of Health Belgium. CSS-9485, revision 2019. Available from: https:\/\/www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/shc_9485_meningococcal_vaccination_2019_1.pdf Accessed: 2021 Dec 8."},{"key":"cit0032","unstructured":"Brazilian Society of Pediatrics. Calend\u00e1rio de Vacina\u00e7\u00e3o da SBP 2020. Available from: https:\/\/www.sbp.com.br\/fileadmin\/user_upload\/22268g-DocCient-Calendario_Vacinacao_2020.pdf. Accessed 2021 Dec 8."},{"key":"cit0033","unstructured":"Public Health Canada. Meningococcal vaccine. Canadian immunization guide. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-13-meningococcal-vaccine.html Accessed 2021 Dec 8."},{"key":"cit0034","unstructured":"Public Health Agency of Canada. NACI statement 2014. Available from: http:\/\/publications.gc.ca\/collections\/collection_2014\/aspc-phac\/HP40-104-2014-eng.pdf. Accessed 2021 Dec 8."},{"key":"cit0035","unstructured":"Ministry of Health Chile. Recomendaciones para la vacunaci\u00f3n de pacientes con necesidades especiales por patolog\u00edas o situaciones de riesgo. Available from: https:\/\/vacunas.minsal.cl\/wp-content\/uploads\/2020\/02\/Recomendaciones-para-la-vacunaci\u00f3n-de-pacientes-con-necesidades-especiales.pdf. Accessed 2021 Dec 8."},{"key":"cit0036","unstructured":"Ministry of Health Croatia. National Immunization programme. Available from: https:\/\/zdravlje.gov.hr\/UserDocsImages\/2020%20Programi%20i%20projekti\/Izmjene%20i%20dopuna%20Provedbenog%20programa%20cijepljenja%20II%20u%202020.pdf Accessed 2021 Dec 8."},{"key":"cit0037","unstructured":"Cyprus Paediatrics Society. Recommendations. Available from: http:\/\/www.child.org.cy\/vaccination-2017\/. Accessed 2021 Dec 8."},{"key":"cit0038","unstructured":"Czech National Institute of Public Health. O\u010dkov\u00e1n\u00ed proti meningokokov\u00fdm onemocn\u011bn\u00edm. Available from: http:\/\/www.szu.cz\/ockovani-proti-meningokokovym-onemocnenim. Accessed 2021 Dec 8."},{"key":"cit0039","unstructured":"Czech Vaccinology Society. News: payment for vaccination of children against meningococci from 1.5.2020. Available from: https:\/\/www.vakcinace.eu\/novinky. Accessed 2021 Dec 8."},{"key":"cit0040","unstructured":"Czech Vaccinology Society. Recommendations of the Czech Vaccinology Society of the J. E. Purkyn\u011b Czech Medical Association for Vaccination against Invasive Meningococcal Disease Available from: http:\/\/www.szu.cz\/uploads\/IMO\/2020_Recommendation_vaccination_IMD.pdf Accessed 2021 Dec 8."},{"key":"cit0041","unstructured":"Finnish Institute for Health and Welfare. Meningococcus B vaccine. Available from: https:\/\/thl.fi\/en\/web\/infectious-diseases-and-vaccinations\/vaccines-a-to-z\/meningococcal-vaccines\/meningococcus-b-vaccine. Accessed 2021 Dec 8."},{"key":"cit0042","unstructured":"Haut Conseil de la Sant\u00e9 Publique. HCSPA Bexsero recommendations. Available from: http:\/\/www.hcsp.fr\/Explore.cgi\/Telecharger?NomFichier=hcspa20131025_vaccmeningocoqueBBexsero.pdf. Accessed 2021 Dec 8."},{"key":"cit0043","unstructured":"Greek Paediatric Society. EIA recommendations for vaccines. Available from: http:\/\/e-child.gr\/update-education\/education-recommendations-for-vaccinations\/. Accessed 2021 Dec 8."},{"key":"cit0044","unstructured":"Robert Koch Institute. Recommendations of the standing committee on vaccination (STIKO) at the Robert Koch Institute \u2013 2017\/2018. Available from: https:\/\/www.rki.de\/EN\/Content\/infections\/Vaccination\/recommandations\/34_2017_engl.pdf?__blob=publicationFile Accessed 2021 Dec 8."},{"key":"cit0045","unstructured":"National Immunisation Office Republic of Ireland. Current schedule. Available from: https:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/currentschedule.html. Accessed 2021 Dec 8."},{"key":"cit0046","unstructured":"Israel. IDAC 2019. Available from: https:\/\/www.health.gov.il\/Services\/Committee\/IDAC\/Documents\/CSV_02012019.pdf. Accessed 2021 Dec 8."},{"key":"cit0047","unstructured":"Ministero della Salute Italy. Piano Nazionale prevenzione vaccinale 2017-2019. Available from: http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_2571_allegato.pdf. Accessed: May 2020."},{"key":"cit0048","unstructured":"Ministry of Health Republic of Lithuania. D\u0117l lietuvos respublikos sveikatos apsaugos ministro. 2015 m. BIR\u017dELIO 12 d. \u012fsakymo nr. V-757 \u201eD\u0116L Lietuvos respublikos vaik\u0173 profilaktini\u0173 skiepijim\u0173 kalendoriaus patvirtinimo\u201c pakeitimo. Available from: https:\/\/e-seimas.lrs.lt\/portal\/legalAct\/lt\/TAD\/f4a925d0f50f11e79a1bc86190c2f01a?positionInSearchResults=0&searchModelUUID=1561434a-b283-4be2-87f5-4f556ad37c32. Accessed: May 2020."},{"key":"cit0049","unstructured":"Higher Council of Infectious Diseases Luxembourg. La vaccination contre le meningocoque groupe B. Available from: http:\/\/sante.public.lu\/fr\/espace-professionnel\/recommandations\/conseil-maladies-infectieuses\/meningite\/2018-avis-vaccination-meningocoque-groupe-b.pdf. Accessed 2021 Dec 8."},{"key":"cit0050","unstructured":"Ministry for Health Malta. National immunisation schedule 2020. Available from: https:\/\/deputyprimeminister.gov.mt\/en\/phc\/pchyhi\/Pages\/National-Immunisation-Schedule.aspx. Accessed: Apr 2021."},{"key":"cit0051","unstructured":"The Immunisation Advisory Centre New Zealand. Bexsero. Available from:http:\/\/www.immune.org.nz\/vaccines\/available-vaccines\/bexsero Accessed: Nov 2020."},{"key":"cit0052","unstructured":"Norwegian Institute of Public Health. Meningococcal disease vaccine. Available from: https:\/\/www.fhi.no\/en\/op\/vaccination-guidance\/vaccines-offered-in-norway\/meningococcal-disease\/. Accessed 2021 Dec 8."},{"key":"cit0053","unstructured":"Ministry of Health Poland. Programu Szczepie\u0144 Ochronnych na rok 2019. Available from: https:\/\/gis.gov.pl\/wp-content\/uploads\/2018\/01\/akt.pdf. Accessed 2021 Dec 8."},{"key":"cit0054","unstructured":"Sociedade de Infeciologia Pediatrica e Sociedade Portuguesa de Pediatrica. Recomenda\u00e7\u00f5es sobre vacinas extra programa nacional de vacina\u00e7\u00e3o. Available from: https:\/\/www.spp.pt\/UserFiles\/file\/Seccao_Infecciologia\/recomendacoes%20vacinas_sip_final_28set_2.pdf. Accessed 2021 Dec 8."},{"key":"cit0055","unstructured":"Gabinete do Secret\u00e1rio de Estado da Sa\u00fade. Despacho n.\u00b0 12434\/2019. Available from: https:\/\/dre.pt\/dre\/LinkFicheiroAntigo?conteudoId=127608823. Accessed 2021 Dec 8."},{"key":"cit0056","unstructured":"Istituto per la Sicurezza Sociale San Marino. Vaccinazioni raccomandate. Available from: http:\/\/www.iss.sm\/on-line\/home\/vaccini-e-vaccinazioni\/vaccinazioni-raccomandate.html. Accessed 2021 Dec 8."},{"key":"cit0057","unstructured":"National Institute za Javno Zdravje Slovenia. Available from: https:\/\/www.nijz.si\/sl\/publikacije\/cepljenje-otrok-knjizica-za-starse. Accessed 2021 Dec 8."},{"issue":"1","key":"cit0058","volume":"90","author":"Moreno-P\u00e9rez D","year":"2019","journal-title":"An Pediatr (Engl Ed)"},{"key":"cit0059","unstructured":"Swedish Public Health Agency. Recommendations on preventive measures against invasive meningococcal infection. Available from: https:\/\/www.folkhalsomyndigheten.se\/contentassets\/941f1dd281b24e75b6e6d46d490b4d1d\/rekommendationer-om-forebyggande-atgarder-mot-invasiv-meningokockinfektion.pdf. Accessed 2021 Dec 8."},{"key":"cit0060","unstructured":"Public Health England. Immunisation against infectious disease. Meningococcal: the green book, chapter 22. Available from: https:\/\/www.gov.uk\/government\/publications\/meningococcal-the-green-book-chapter-22. Accessed: Dec 2021."},{"key":"cit0061","unstructured":"Uruguayan Society of Pediatrics. Inform tecnico - enfermedad meningococcia en Uruguay 2017. Available from: https:\/\/www.sup.org.uy\/2017\/12\/21\/informe-tecnico-enfermedad-meningococcia-en-uruguay-2017\/. Accessed 2021 Dec 8."},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6909a1"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31921-3"},{"key":"cit0064","unstructured":"National Immunisation Office Republic of Ireland. Primary childhood immunisation schedule. Available from: https:\/\/www.hse.ie\/eng\/health\/immunisation\/pubinfo\/pcischedule\/immschedule\/. Accessed: May 2020."},{"key":"cit0065","unstructured":"Istituto per la Sicurezza Sociale San Marino. Delibera n.38 del 21\/03\/18 Modifica calendario vaccinale per le vaccinazioni obbligatorie e raccomandate. Available from: http:\/\/www.iss.sm\/on-line\/home\/vaccini-e-vaccinazioni\/vaccinazioni-obbligatorie-a-san-marino\/riferimenti-legislativi.html. Accessed: Apr 2021."},{"key":"cit0066","unstructured":"Ceska Vakcinologicka Spolecnost CLS JEP. Available from: https:\/\/www.vakcinace.eu\/. Accessed: Jul 2020."},{"key":"cit0067","unstructured":"Gabinete do Secret\u00e1rio de Estado da Sa\u00fade. Aprova o novo esquema vacinal do Programa Nacional de Vacina\u00e7\u00e3o (PNV), revo-gando, com exce\u00e7\u00e3o do seu n. 6, o Despacho n.\u00b0 10441\/2016, de 9 de agosto. Available from: https:\/\/dre.pt\/application\/conteudo\/127608823. Accessed: Aug 2020."},{"key":"cit0068","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). Strat\u00e9gie de vaccination pour la pr\u00e9vention des infections invasives \u00e0 m\u00e9ningocoques: le s\u00e9rogroupe B et la place de BEXSERO\u00ae. Available from: https:\/\/www.has-sante.fr\/jcms\/p_3066921\/fr\/strategie-de-vaccination-pour-la-prevention-des-infections-invasives-a-meningocoques-le-serogroupe-b-et-la-place-de-bexsero. Accessed 2021 Nov 27."},{"key":"cit0069","unstructured":"European Centre for Disease Prevention and Control. ECDC Vaccine Scheduler. Available from: https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=48&SelectedCountryIdByDisease=\u22121. Accessed: Aug 2020."},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50481"},{"key":"cit0071","unstructured":"Public Health England. The routine immunisation schedule. From June 2020. Available from: https:\/\/www.gov.uk\/government\/publications\/the-complete-routine-immunisation-schedule. Accessed: Apr 2021."},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.067"},{"key":"cit0073","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI interim position statement on use of Bexsero meningococcal B vaccine in the UK. July 2013. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224896\/JCVI_interim_statement_on_meningococcal_B_vaccination_for_web.pdf. Accessed: May 2020."},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61572-X"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61861-9"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61924-8"},{"key":"cit0077","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI position statement on use of Bexsero meningococcal B vaccine in the UK. March 2014. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/294245\/JCVI_Statement_on_MenB.pdf. Accessed: May 2020."},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5725"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-318047"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.3201\/eid2202.150369"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60842-4"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.076"},{"key":"cit0083","unstructured":"National Immunisation Office Republic of Ireland. Immunisation. Meningococcal B. Available from: https:\/\/www.hse.ie\/eng\/health\/immunisation\/hcpinfo\/othervaccines\/meningococcalb\/#Paracetamol%20after%20MenB%20vaccine. Accessed: Apr 2021."},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819000396"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.155218"},{"key":"cit0086","unstructured":"National Centre for Pharmacoeconomics. Economic evaluation of a universal meningitis B vaccination programme in Ireland. Available from: http:\/\/www.ncpe.ie\/wp-content\/uploads\/2018\/02\/Meningitis-B-vaccine-Feb-2014.pdf. Accessed: Nov 2020."},{"key":"cit0087","unstructured":"Rota M, Bella A, D\u2019Angelo F, et al. Vaccinazione anti-meningococco B: dati ed evidenze disponibili per l\u2019introduzione in nuovi nati e adolescenti. Roma: istituto Superiore di Sanit\u00e0; 2015. (Rapporti ISTISAN 15\/12). Available from: https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwi3juDajNX0AhVDZMAKHTBLA34QFnoECAIQAQ&url=https%3A%2F%2Fwww.scienzainrete.it%2Ffiles%2F15_12.pdf&usg=AOvVaw1E2zXD1bsfZKm46V6TRztG. Accessed: Aug 2020."},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.09.055"},{"issue":"3","key":"cit0089","first-page":"E133","volume":"56","author":"Gasparini R","year":"2015","journal-title":"J Prev Med Hyg"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.12.30176"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7426-5"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.3201\/eid2203.150928"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2011.10.002"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1160177"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030469"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0730-y"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-03914-8"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219477"},{"key":"cit0099","unstructured":"Reposit\u00f3rio Cient\u00edfico do Instituto Nacional de Sa\u00fade. Epidemiology of invasive meningococcal disease in Portugal in the last decade \u2013 2007-2016. Available from: http:\/\/repositorio.insa.pt\/handle\/10400.18\/5176. Accessed: Aug 2020."},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1547606"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.071"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900236"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1636"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.07.009"},{"key":"cit0105","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 (HAS). La HAS recommande la vaccination des nourrissons contre le m\u00e9ningocoque B. Les pros de la petit enfance. Available from: https:\/\/lesprosdelapetiteenfance.fr\/la-has-recommande-la-vaccination-des-nourrissons-contre-le-meningocoque-b. Accessed 2021 Nov 27."},{"key":"cit0106","unstructured":"World Health Organization. Principles and considerations for adding a vaccine to a national immunization programme. 2014. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/111548\/9789241506892_eng.pdf;jsessionid=75F9B7C9D6282EC802B908056D1EEE98?sequence=1. Accessed: Jul 2020."},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-019-01129-z"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00261"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.09.004"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.09.1286"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.06.018"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2022.2021881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T05:27:02Z","timestamp":1700112422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2022.2021881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/14760584.2022.2021881"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2022.2021881","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}